Visit the Exhibit Hall

By providing education, accelerating innovation, supporting research, and promoting advocacy, the American Society of Breast Surgeons empowers breast surgeons and the clinical care team to optimize patient outcomes.

AccuTec has been engineering and manufacturing blades for more than a century. Our AccuThrive medical blades are engineered for consistency and with the precision to handle your most challenging cases in plastic surgery. Our commitment to excellence begins with our proprietary MicroCoat® enrichment technology that provides a microscopic, multi-layered cutting edge to help create a smooth and resistance-free incision.

Agendia is a leading provider of innovative solutions in precision oncology, specializing in early-stage breast cancer. They offer reliable biological insights for personalized treatment decisions, using advanced genomic assays like MammaPrint® and BluePrint®. These assays help clinicians quickly identify the most effective treatment plan, reducing the risks of over- and under-treatment.

Founded in 2003 in Amsterdam, Agendia is headquartered in Irvine, California, with a state-of-the-art laboratory. Led by world-renowned scientists and oncologists, Agendia is dedicated to advancing genomic insights through ongoing research. Notably, their FLEX Study is the world’s largest Real-World Evidence-based Breast Cancer database, aiming to revolutionize precision in breast cancer management. With cutting-edge technology, research, and innovation, Agendia strives to shape the future of precision oncology and make a significant impact in the fight against breast cancer.

Ambry Genetics, a wholly owned subsidiary of Tempus, excels at translating scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind the genetic disease. www.ambrygen.com

American Breast Care is one of the leading producers of post-mastectomy products supplying: mastectomy bras, breast forms, custom prosthetics, post-surgery products, truncal compression, and accessories worldwide. At ABC, we take pride in our commitment to the amazing women that we serve. Our goal is not only to provide quality products & education but to facilitate a positive & impactful experience in the lives of those within our reach.

Amoena is the global leader in clinically informed post-operative recovery solutions, supporting breast surgeons in optimizing healing, comfort, and long-term outcomes for their patients. For more than 50 years, we have advanced the science of post-surgical care with a portfolio that integrates medical-grade compression, lymphatic support, and stability-focused garment engineering—each designed to complement surgical technique and enhance overall outcomes.

Our postoperative collection includes targeted compression garments, drain-management solutions, and soft recovery wear that promote controlled support, reduce post-surgical edema, and help patients maintain mobility during the earliest phases of healing. Amoena’s products are trusted in hospitals, comprehensive breast centers, and accredited boutiques across the U.S. and Canada, supported by national contracts and GPO availability for seamless integration into clinical pathways.

Surgeons choose Amoena because our solutions are clinically engineered to complement their surgical approach, improve patient comfort, and support a smoother return to daily life. Every product reflects decades of research, ISO-certified manufacturing, and collaboration with breast surgeons, lymphedema specialists, and certified mastectomy fitters worldwide.

For patients requiring long-term symmetry solutions, Amoena also offers the most advanced portfolio of silicone breast forms, including the award-winning Adapt Air, the first adjustable air-chamber breast form designed to deliver personalized volume control, improved biomechanical balance, and enhanced post-operative comfort as the body continues to heal.

With consistent clinical performance, national availability, and a seamless continuum of care from surgery through full recovery, Amoena remains the trusted partner of surgical teams dedicated to delivering the highest standard of post-mastectomy care.

Applied Medical designs, develops and manufactures innovative products that enable advanced surgical procedures and optimize patient outcomes. As a global medical device company, Applied Medical is equally committed to improving the affordability and accessibility of high-quality healthcare. We also further minimally invasive surgery by offering sophisticated training, including workshops, symposia and our simulation-based programs.

Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We offer tests for physicians treating patients with breast cancer. Our portfolio includes tests predicting response to neoadjuvant therapy, response to chemotherapy in the adjuvant setting and prognostics for all subtypes of breast cancer.

AURA Health Technologies develops ultrasound-based solutions for the diagnosis and therapy of breast cancer. Our mission is to empower health care providers with real‑time, data‑driven insights that enable more accurate, more efficient, and ultimately more successful breast ultrasound imaging.

AURA’s first product is an ultrasound system with AI software that enables real-time detection of breast biopsy markers, previously placed in the breast - ClipGuide. Built in close collaboration with leading physicians and validated in multiple clinical studies across the United States and Europe, ClipGuide localizes biopsy markers during outpatient follow-up evaluations, planning for interventional procedures and planning for surgical procedures, supporting physicians in providing the best possible treatment.

bcalmed, Inc., a 501(c)(3) non-profit, and the bcalmed bag were created to help patients manage post-operative drains after surgical procedures such as mastectomies and lumpectomies. The bcalmed bag is provided free of charge to any patient to ease their journey to recovery.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com

Breast360.org and the Breast360 Foundation are your go-to resources for patient education and collaboration opportunities with multidisciplinary teams. Stop by our booth in the exhibit hall or contact Ryan Cliche at rcliche@breast360.org for information about upcoming speaking opportunities, educational resources for patients and caregivers, collaboration with multidisciplinary teams, or supporting our mission.

Cairn Surgical, Inc. is an early commercial stage company improving healthcare outcomes and economics with image-derived, patient-specific, 3D-printed, state-of-the-art guidance devices. The Company’s first product, the Breast Cancer Locator (BCL), is a surgical guide for breast cancer lumpectomy procedures. Initial single arm studies show significant improvements in clinical outcomes by reducing the positive margin rate. A randomized, prospective trial was recently completed and included in a denovo submission to FDA. The BCL is commercially available in Europe and under review with FDA for marketing clearance in the U.S.

CancerIQ is the only cancer-focused precision health platform that empowers healthcare providers to detect cancer earlier and prevent it altogether across all patient populations. Integrated directly into real-time EHR workflows, CancerIQ makes it easy to gather comprehensive patient data, automatically map it to the latest evidence-based guidelines, and expand access to personalized care plans, cutting-edge clinical solutions, and genomic innovations.

At Cardinal Health Nuclear & Precision Health Solutions, our products and services are essential in helping support nuclear medicine providers as they care for their patients. Our portfolio of radiopharmaceuticals includes agents used in lymphatic mapping and guiding sentinel lymph node biopsies in patients with breast cancer.

Care Wise has been a key part of the Southern Scientific product portfolio since 2015. The company has many years of experience and expertise working in the specialist health sector. Indeed, as part of the LabLogic group, the company is a key supplier to the healthcare sector worldwide. CareWise introduced the C-Trak Apollo, a wireless gamma probe, in 2021. Since its launch, this innovative probe - which provides accurate and precise detection of radiation for use during sentinel node biopsies in breast, melanoma and other types of cancer - has gained immense popularity, being widely adopted by hospitals across the USA and Europe.

For 50 years, CARTI has been dedicated to redefining cancer care, offering a full spectrum of services designed to support patients through every stage of their journey. As a not-for-profit multidisciplinary cancer care provider, CARTI brings together expert physicians, advanced technology and a compassionate approach to deliver comprehensive treatment. With a network of locations across Arkansas including the state's first cancer-focused surgery center, CARTI ensures that high-quality patient-centered care is always within reach.

CARTI’s commitment to breast cancer care extends beyond treatment. Our expert team of breast surgical oncologists, medical oncologists, radiation oncologists, genetic counselors and supportive care specialists work collaboratively to provide individualized evidence-based treatment plans. The Breast Center at CARTI offers a full range of services including advanced imaging, 3D mammography, breast MRI, ultrasound, biopsy and surgical management of both benign and cancerous conditions. By integrating the latest advancements with a personalized patient-first approach, we empower women with knowledge, confidence and compassionate support at every step.

Our belief in whole-patient care is reflected in the resources available to support those facing a breast cancer diagnosis. CARTI’s comprehensive survivorship programs, genetic counseling services, lymphedema therapy and wellness initiatives ensure that patients have access to the tools they need to navigate treatment and recovery. The Bridge at CARTI, our patient support program, offers financial advocacy, counseling, wellness services and a salon and appearance center—because we understand that cancer care goes beyond medicine.

At CARTI, we are more than a cancer treatment provider—we are a trusted partner in care committed to innovation, accessibility and the best possible outcomes for every patient.

Cirdan is a leading provider of informatics and imaging solutions that support and speed up patient diagnosis. Headquartered in the UK, with offices in Canada and Australia, Cirdan is recognised as one of the leading suppliers of laboratory information systems (LIS) worldwide.

Innovation is at the heart of Cirdan, and we are committed to improving the treatment of breast cancer and helping surgeons reduce readmission rates by providing rapid and accurate imaging at the point of care for both core biopsy and surgical specimens. Our family of imaging products aid clinicians in the diagnosis of breast cancer in patients across the globe. Solas OR is our dedicated X-ray specimen cabinet designed for surgical and biopsy suites, providing high image quality, streamlined workflow, and reduced procedure times. Enabling clinical staff and surgeons to accurately, and securely manage patient cases as efficiently as possible.

Find out more at www.cirdan.com.

Founded by world-renowned medical imaging scientists from the University of Chicago, Clarix Imaging’s mission is to empower clinicians with clear tumor visualization and intelligent analysis for precision and personalized medicine based on breakthrough innovations in imaging science and AI. Our first product is the FDA cleared true 3D VSI-360™, which offers surgeons and radiologists unprecedented clarity for intraoperative specimen margin visualization in breast cancer surgeries such as lumpectomy – right inside the operating room.

For over 35 years, CooperSurgical has empowered surgeons with innovative solutions, elevating precision, efficiency, and patient outcomes in the most challenging surgical procedures. Our proven tools are designed to meet the demands of intricate surgeries —helping you perform at the highest level.

See the Visible Difference® with Designs for Vision' s Panoramic Field Surgical Loupes. The 3.5x Panoramic expand the field to 11cm x 9cm and the 4.5x Panoramic have a 9cm x 7cm field. Experience Designs for Vision' s High-Definition Imaging Surgical Headlights, providing 45% brighter illumination.

Dilon Technologies Inc., a medical device manufacturer, based in Newport News, Virginia, strives to improve the quality of life by providing a wide range of innovative medical solutions that benefit patients around the world. Dilon has a strong medical device portfolio; HEMOBLAST Bellows, the only combination powdered hemostat that contains collagen, thrombin and chondroitin sulfate, the Navigator System, a trusted brand and world-renowned surgical gamma probe for radio-guided lymphatic mapping and tumor localization, the MarginProbe, a groundbreaking technology for accurate margin assessment in breast cancer surgery, and the CoPilot, an innovative, portable, and easy to use video laryngoscope.

Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis.

FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound, delivers solutions that meet your imaging needs. Sonosite has earned worldwide recognition for its innovative product line, educational programs, and advocacy for ultrasound’s many benefits.

Hoag Memorial Hospital Presbyterian is proud to train the next generation of Oncoplastic breast surgeons as the first Advanced Oncoplastic Breast Fellowship program in the United States. This one-year program will provide a broad multi-disciplinary clinical experience in all aspects of oncoplastic breast surgery. The fellow will receive in depth exposure in breast surgery and plastics and reconstructive surgery. The surgical training experience will cover level 1 and level 2 oncoplastic procedures. Breast imaging exposure includes training with fellowship trained breast imagers with experience in mammography, ultrasound, breast MRI, and various biopsy techniques. Graduates of the Oncoplastic Breast Fellowship at Hoag will have the tools and experience to utilize these techniques in their practice.

Here at Hologic, we are on a mission to revolutionize the patient experience and improve outcomes, because we believe that all women deserve best-in-class breast health care.

We’re the only company to offer innovative solutions from screening through to surgery, helping to make it easier to detect, diagnose, and treat breast cancer earlier, while supporting improved patient outcomes.

Our breast surgery technologies – including the full Sentimag® platform - are backed by clinical evidence, providing healthcare professionals with additional confidence to make informed decisions for their patients.

Together, we can stay ahead of the curve and save more lives from breast cancer.

As a proud member of the Arjo family, we believe that great healthcare is always a collective effort.

The greatest contribution we can provide to patients, and the professionals who care for them, is confidence. This is what we have been striving for since 1979, with innovative solutions in vascular care, fetal and patient monitoring. Solutions that can assist clinicians in improving outcomes and enhancing patient wellbeing.

Whether it’s the safe delivery of a new life, improving the day-to-day quality of life or monitoring life’s vital signs, we aim for clinical excellence and improved performance, for life.

IceCure is transforming breast cancer care by bringing patients the choice of minimally invasive cryoablation. Now the first and only FDA cleared medical device for the local treatment of breast cancer, the ProSense® System uses advanced liquid-nitrogen technology to generate ultra cold temperatures to destroy breast tumors by freezing them. ProSense® empowers patients with the option of a less invasive, office-based procedure instead of surgical tumor removal.

ProSense® Cryoablation is indicated for the local treatment of low-risk breast cancer in patients aged 70 and above with endocrine therapy, including those patients not suitable for surgical breast cancer treatment.

The FDA indication was largely based on IceCure’s landmark ICE3 Study, which found ProSense to be safe and effective with a 3.1% IBTR for those patients treated with cryoablation and endocrine therapy. 99.1% of patients and 97% of physicians expressed they were very satisfied or satisfied with the cosmetic outcome of the procedure. Return to routine activity was generally within 24 hours.

ProSense® currently has FDA clearance for use as a cryosurgical tool in the destruction of fibroadenomas and in the fields of general surgery, thoracic surgery, gynecology, oncology, proctology, and urology. The system is CE-marked and is available globally including across Europe, Brazil, and Asia.

ImpediMed’s SOZO® Digital Health Platform provides clarity across the cancer journey starting at diagnosis through survivorship, by providing real-time insights into how the body is changing, enabling earlier intervention by identifying trends before symptoms arise from problems like lymphedema and loss of muscle mass. With L-Dex® Analysis for lymphedema assessment, and BodyComp™ Analysis for whole body insights, SOZO helps to empower patients by providing personalized survivorship care.

Innoblative is a private medical device company addressing clinical unmet needs for patients with breast cancer and other soft tissue diseases. We are developing advanced energy-based surgical solutions to help improve the way surgeons coagulate and ablate soft tissue to achieve better care for patients. Innoblative has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the company’s SIRA® RFA Electrosurgical Device.

The SIRA® device is investigational for use in BCS and is not yet available for sale in the United States.

The SIRA® device is cleared for intraoperative coagulation and ablation of soft tissue.

Intuitive®, headquartered in Sunnyvale, Calif., was founded in 1995 to create innovative, robotic-assisted systems that help empower doctors and hospitals to make surgery less invasive than an open approach. Since da Vinci® became one of the first robotic-assisted systems cleared by the FDA for general laparoscopic surgery, it’s taken robotic-assisted surgery from concept to reality. Working with doctors and hospitals, we’re continuing to develop new, minimally invasive surgical platforms and future diagnostic tools to help solve complex healthcare challenges around the world. Innovating for minimally invasive care. It’s the passion that drives us at Intuitive.

Introducing IsoSphere™, an intraoperative, intracavity, low-dose-rate device delivering targeted radiation. This bioabsorbable device is placed at the time of the lumpectomy and is a one-time breast cancer treatment with no removal necessary. IsoSphere™ is pioneered by IsoAid using our 25+ years of proven success treating cancer with Brachytherapy. We manufacture Palladium-103 and Iodine-125 seeds for treatment with the IsoSphere™ and as a diagnostic tool for tumor localization before a lumpectomy. Radioactive Seed Localization (RSL) is as an alternative to wire localization before a lumpectomy with benefits for both the patient and the physician. All of our products are custom-made and delivered sterile and ready to implant. At IsoAid we are committed to helping you treat your breast cancer patients with the best products available. Please stop by booth #340 and allow us to show you our new IsoSphere device.

K-LOCK® by KMD Surgical Solutions is a sutureless securement device designed to standardize and simplify the stabilization of surgical drains. By eliminating the need for sutures, K-LOCK enhances patient comfort, reduces needle-stick risk, and improves consistency in securement. Compatible with a wide range of drain types and sizes, K-LOCK supports efficient workflows while elevating both patient and clinician experience.

Koning Corporation is a global health technology company making strides in the breast imaging industry with its innovative Koning Vera Breast CT (KBCT). Koning has been developing cone-beam CT technology for over two decades and holds over 120 patents globally. The Koning Vera system offers a new approach to breast imaging. This system provides high-contrast, real 3D images of the breast with exceptional spatial resolution, without the discomfort of compression, and in a rapid 7-second exposure. Importantly, it operates at radiation levels comparable to diagnostic mammograms. The company's mission is to revolutionize medical imaging, aiming to significantly enhance early disease detection, diagnosis, intervention, and treatment.

At KUBTEC®, our passion is developing transformative technologies that enable precision surgery for breast cancer. For over 21 years, we have led the way in specimen imaging and margin assessment technology, offering the widest range of specimen radiography systems for the OR, Pathology Lab and Biopsy Suite. Building on this legacy, we now provide an innovative gamma probe detection system that seamlessly integrates with our imaging solutions.

At Lumicell, our mission is to improve the way cancer surgery is performed, starting with breast cancer.  Our innovative, fluorescence-guided imaging technology is designed to illuminate cancerous tissue inside the body cavity following initial lumpectomy to help surgeons achieve a more complete surgical resection.

Fore more information, visit www. lumicell.com and follow us on Facebook, LinkedIn, and X.

At Mammotome, we are committed to providing innovative technology to help clinicians accurately diagnose breast cancer, never forgetting that at the core of every diagnosis is the patient. We believe that an accurate diagnosis starts with the right tissue. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. Our comprehensive portfolio includes Mammotome breast biopsy devices, tissue markers, the Neoprobe® Gamma Detection System as well as distribution of the Sirius Medical Pintuition® Localization System for radiation-free sentinel lymph node biopsy.

Maple Tree Cancer Alliance improves the lives of cancer patients through individualized exercise training, nutrition education, and supportive care delivered in partnership with hospitals and community health systems. Our nationally recognized exercise oncology model integrates comprehensive assessment, individualized programming, and multidisciplinary collaboration.

Masthead is dedicated to enhancing patient comfort and expediting recovery through innovative post-surgical solutions. Our specialized surgical bras are meticulously designed by a physician who was also a patient to provide optimal support, minimize discomfort, and facilitate healing. Product Range: • Post Surgical Bras: Offering a range of styles and sizes to cater to diverse needs, our post-mastectomy bras provide gentle support, reduce swelling, and promote healing. Designed for various procedures, including breast surgeries such as lumpectomy, mastectomy, oncoplastic surgery, reconstruction, augmentation, reduction, orthopedic and Cardio-Thoracic surgery. Our post-surgical bras offer compression, support, and comfort. Key Features and Benefits: • Comfort and Support: Our bras are crafted from soft, breathable fabrics that minimize irritation and maximize comfort. • Optimal Fit: We offer a wide range of sizes (11) and styles to ensure the perfect fit for every patient. • Durability: Our bras are built to withstand the rigors of post-surgical recovery, providing long-lasting support. • Ease of Use: Our bras have front closure and 5 points of easy-to-use closures and adjustable straps make it simple for patients to put on and take off their bras. • Recognizable Color: Our Pink bras are designed to be both functional, identifiable, and stylish, offering a discreet and comfortable solution. Our Value Proposition: By partnering with Masthead hospitals can: • Enhance Patient Satisfaction: Provide superior comfort and support to patients undergoing surgical procedures. • Accelerate Recovery: Minimize discomfort and promote faster healing. • Reduce Readmission Rates: Contribute to improved patient outcomes and reduced healthcare costs. (Ref Intermountain Cardiac Study) • Strengthen Brand Reputation: Associate your hospital with high-quality, patient-centered care. Our Commitment to Quality and Service: rigorous quality control, prompt delivery and dedicated support.

Myriad Oncology, a business unit of genetic testing and precision medicine leader Myriad Genetics, provides an expanding portfolio of advanced genetic and tumor genomic testing solutions. Myriad Oncology products support each step in the cancer care continuum, empowering clinicians and their patients with confidence and clarity to navigate the unique challenges of each cancer journey.

SignateraTM Residual Disease (MRD) test is a custom-built circulating tumor DNA (ctDNA) test for molecular residual disease (MRD) assessment and treatment response monitoring in patients previously diagnosed with cancer. The SignateraTM test is personalized and tumor-informed, providing each individual with a customized blood test tailored to fit the unique signature of clonal mutations found in that individual’s tumor. This maximizes Signatera’s accuracy for detecting the presence or absence of residual disease in a blood sample, even at levels down to a single tumor molecule in a tube of blood. Signatera is intended to detect and assess how much cancer is left in the body, to identify recurrence earlier and to help optimize treatment decisions.

Not Putting on a Shirt is a 501(c)(3) patient advocacy nonprofit promoting an optimal standard of care for patients going flat after mastectomy (aesthetic flat closure, or AFC). NPOAS provides education, tools, and peer support to empower patients and educate medical providers, supports research on AFC, and conducts institutional advocacy to improve outcomes for patients.

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.

Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.

OSF HealthCare is an integrated health system founded by The Sisters of the Third Order of St. Francis.

Headquartered in Peoria, Illinois, OSF HealthCare employs almost 26,000 Mission Partners in 171 locations, including 17 hospitals, with 2,305 licensed beds, 200 OSF Medical Group primary care and specialty care clinics, 41 urgent care locations, and two colleges of nursing throughout Illinois and Michigan.

The OSF HealthCare physician network employs more than 2,215 primary care, specialist and advanced practice providers.

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing non-opioid options to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid options for treating pain: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

Perimeter Medical Imaging AI is driven to transform cancer care by developing advanced imaging systems that improve patient outcomes and reduce healthcare costs.

Surgeons have worked for years to innovate every step in the diagnosis and treatment plan for their cancer patients, with the ultimate goal of improving survivability and quality of life. Yet, intraoperative margin assessment remains one of their most pressing problems.

Current tools in the operating room help surgeons look for signs of disease, but they don’t show the very fine details hidden in tissue. Optical Coherence Tomography, or OCT, uses light to reveal tiny patterns and layers inside tissue at the cellular level, giving surgeons real-time insights in the operating room - rather than the current standard of care which can take up to 10 days for lab results.

Perimeter’s proprietary Artificial Intelligence aims to make OCT even more powerful. Trained on thousands of OCT images, Perimeter’s AI software is designed to find areas of tissue that look suspicious and guide the surgeon to those areas. This AI-human partnership offers assistance with image review while still leaving the clinical decision making squarely in the hands of the surgeons.

Founded in 2013, with U.S. headquarters in Dallas, Texas, Perimeter continues to innovate at the intersection of imaging, big data, and AI—working toward a future where no patient has to experience the trauma of being called back for a second surgery.

Piedmont is empowering Georgians by transforming health care. We continue to fuel Georgia’s growth through safe, high-quality care close to home through an integrated healthcare system that provides a hassle-free, unified experience. We are a private, not-for-profit organization with more than 12,000 donors annually that for centuries has sought to make a positive difference in every life we touch in the communities we serve.

Across our 2,171 physical locations, we care for more than 4.5 million patients and serve communities that comprise 85% of Georgia’s population. This includes 27 hospitals, 113 immediate care locations, 1,875 Piedmont Clinic physician practices and nearly 3,600 Piedmont Clinic members. Our patients conveniently engage with Piedmont online, as they scheduled more than 560,000 online appointments and over 120,000 virtual visits.

With nearly 50,000 caregivers, we are the largest Georgia-based private employer of Georgians, who all came for the job but stayed for the people. In 2024 and 2023, Piedmont has earned recognition from Newsweek as one of America’s Greatest Workplaces for Diversity and also as one of America's Greatest Workplaces for Women. In 2022, Forbes ranked Piedmont on its list of the Best Large Employers in the United States. Piedmont provided more than $607 million in community impact in Fiscal Year 2024.

Plexāā is a pioneering Medtech company focused on Prehab, improving surgical outcomes through devices and digital products. Its flagship device, BLOOM⁴³, enables patients to supraphysiologically precondition their skin, potentially reducing the risk of wound healing complications such as infection and skin necrosis, which affect up to one in three women undergoing breast reconstruction surgery.

Plexāā is also exploring the application of this technology in other surgical fields, including obstetrics for C-sections, orthopedics for joint operations, and general and vascular surgery, with a commitment to improving pre-operative preparation for surgery and patient outcomes.

PreludeDx is a leader in personalized breast cancer diagnostics, offering precision tools that empower patients and physicians worldwide to make more informed, shared treatment decisions. The company offers DCISionRT for Ductal Carcinoma In Situ (DCIS) and AidaBreast for early-stage invasive breast cancer, which provide genomic insights into a patient’s unique tumor biology. These personalized, clinically actionable test results help guide surgical and radiation treatment decisions, reducing the risks of over- or undertreatment. The company utilizes multi-omic technology to provide comprehensive prognostic and predictive information at critical treatment decision points to enhance patient care.

Radialis is a medical imaging company developing next-generation, organ-targeted PET systems designed to deliver high-definition molecular imaging with unprecedented sensitivity and specificity. The company’s platform leverages advances in solid-state detector technology to enable compact, low-dose PET imaging focused on specific organs.

Radialis’ lead system is optimized for breast cancer applications, providing three-dimensional, quantitative imaging that supports surgical planning, assessment of disease extent, and evaluation of treatment response. Clinical studies have demonstrated sensitivity comparable to MRI with significantly improved specificity, helping clinicians reduce false positives, unnecessary biopsies, and re-operations while maintaining confidence in surgical margins.

The system is FDA-cleared, reimbursed in the U.S., and designed for easy deployment within existing clinical workflows, with a small footprint and minimal infrastructure requirements. Radialis is currently building clinical momentum through pilot programs and academic collaborations, while expanding the platform’s applicability to additional organs and molecular imaging use cases.

Ronin Surgical: the Standard in Surgical Lighting. Ronin's latest model, the X7, is the lightest, brightest, longest-running surgical headlight on the market. Contact Ronin at +1 415.226.9414 or Contact@RoninSurgical.com. www.RoninSurgical.com

SAGA Diagnostics® is redefining the early detection of molecular residual disease (MRD), empowering treatment decisions with greater insight and confidence. Pathlight™, the company’s flagship product, is an ultra-sensitive, blood-based, multi-cancer MRD test that is now available for commercial use in the U.S. for patients with early-stage breast cancer.

Histolog® Scanner from SamanTree Medical provides rapid imaging of microstructures on the surface of tissue specimens. The ability to deliver high-resolution digital images in minutes, without resource-intensive processing, enables immediate image assessment and real-time remote collaboration to assist decision making by physicians. https://www.us.samantree.com/important-safety-informations

SimBioSys is an AI-driven precision medicine company revolutionizing how cancer is understood and treated. By converting standard medical imaging into AI-powered, decision-driving intelligence, SimBioSys empowers clinicians with clear, contextual, and actionable insights to individualize care. Its FDA-cleared TumorSight™ Viz platform and in-development TumorSight™ Risk solution combine AI and spatial biophysics to deliver greater confidence, precision, and personalization in cancer treatment. For more information, visit www.simbiosys.com.

The only seroma prevention device that is FDA cleared, battery powered, fully closed surgical drainage system that provides continuous deep tissue negative pressure therapy. This allows sooner drain removal, improves patient comfort, and supports faster recovery. Lightweight, discreet, and easy to use, SOMAVAC improves outcomes and the patient’s experience.

Advancing breast-conserving and reconstruction surgery with a combination of clinically-differentiated biologics, fluorescence and lighted visualization tools to help you see and do more. Together with our customers, we are driven to make healthcare better.

Manufacturer of polymer composite surgical instruments.

SYLKE® is a 99.9% silk fibroin woven mesh with a gentle pressure-sensitive acrylic adhesive, engineered for biocompatible wound closure. SYLKE® offers a safe and effective alternative to traditional cyanoacrylate-based wound closure systems and helps reduce the risk of Medical Adhesive-Related Skin Injuries (MARSI).

SYLKE® incorporates silk fibroin, a natural material known for its strength and biocompatibility. The wound closure system features a breathable silk fibroin mesh that provides flexibility and comfort, paired with a pressure-sensitive adhesive for secure wear. A protective peel-off liner ensures simple and efficient application.

The US Oncology Network believes local cancer care is better care. We empower the delivery of advanced integrated cancer care through our network of independent physicians who share expertise and resources to provide quality, value-based care close to home.

Our clinical and business support capabilities, expertise and industry-leading technologies keep local practices at the forefront of high quality, efficient care delivery while enabling practice success, quality of life and financial security for physicians.

Thompson Retractor is the global leader in innovative, table-mounted retractor sets, known for exceptional customer service and timely, tailored solutions. The Thompson Retractor is engineered to support a wide range of surgical specialties, providing optimal visualization through low-profile instruments that minimize obstruction and deliver a clearer view of the surgical site. With a modular frame, Thompson Retractor offers unmatched versatility and adapts seamlessly to meet your unique exposure needs.

Founded after her mother’s breast cancer diagnosis, Leah Wyrick Smith created the Resilience Bra—an insurance-reimbursable post-surgical bra for breast cancer and cosmetic surgery patients. Developed with input from over 500 physicians and patients, it aims to assist patients in their post-op healing while providing lasting comfort, support, and confidence from the operating room through recovery.

Vector Surgical is the global leader in tissue orientation devices that provide the most accurate designation of excised tissue margins in cancer surgery. Our devices integrate the needs of surgeons, pathologists and radiologists, providing tools that enable the highest level of care for their cancer patients. Leading hospitals and physicians are eliminating error and improving outcomes with our products: MarginMarker™ sterile ink kits, CorrectClips™ radiographic clips and the SilversteinWrap™.

Videra Surgical is an oncology surgery company focused on breast cancer treatment with our tumor bed marker, VeraForm®. We strongly believe that helping radiation oncologists better identify the tumor bed is essential for the continuum of care for breast cancer patients. VeraForm is an adaptable tissue marker comprised of a radiopaque filament that provides a continuous, 3D, multi-plane and permanent mark of a tumor bed. VeraForm is easily viewed by the radiation oncologist under X-ray and CT/CBCT, but it does not create artifact in MRI or ultrasound, as it is completely metal-free. VeraForm is 510(k) cleared and has been placed in thousands of patients in a rapidly growing number of U.S. centers. VeraForm is designed to provide a precise depiction of the tumor bed, allowing radiation oncologists to be more targeted in the delivery of radiation, in an attempt to avoid over-radiating and possibly damaging collateral tissue and organs.

XpediteMD, Inc. is a healthcare technology company offering cloud-based digital patient navigation and care management solutions that eliminate treatment delays, improves cancer care quality, and ensures the financial sustainability of patient navigation.

The medical technology business of ZEISS offers a comprehensive portfolio of innovative solutions that meet the needs of reconstructive microsurgery. With its customer centric design philosophy, the surgical microscopes from ZEISS support various applications in the fields of reconstructive microsurgery ranging from breast reconstruction, lymphedema microsurgery to head and neck surgery.